Internal Medicine, Gastroenterology · New York, NY
NPI
1891886842
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
17 Elizabeth Street, # 608
New York, NY, 10013
Phone (212) 219-8031
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
169 services
Medicare patients, 2024
92
Average age 74
Drug cost, 2024
$727K
1,937 prescriptions
Company payments, 2025
$78K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Danny Chu was code 99214 (office e&m - established), 46 times for 38 patients. In total Danny Chu billed 169 services in 11 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 46 | 38 | $110.15 | $5,067 |
| 43239 Upper GI Endoscopy | Office | 27 | 27 | $328.11 | $8,859 |
| 45378 Lower GI Endoscopy - Other | Office | 27 | 27 | $262.63 | $7,091 |
| 99213 Office E&M - Established | Office | 23 | 22 | $73.72 | $1,696 |
| 99203 Office E&M - New | Office | 11 | 11 | $99.47 | $1,094 |
By year: 2022 $49K for 246 services; 2023 $34K for 191 services; 2024 $30K for 169 services.
Medicare prescription drug claims, 2024
In 2024, the drug Danny Chu prescribed most often to Medicare patients was Omeprazole, with 554 prescriptions and refills. In total Danny Chu wrote 1,937 Medicare prescriptions that cost $727K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 554 | 589 | 314 | $4,394 |
| Vemlidy Tenofovir Alafenamide | 447 | 453 | 47 | $645K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 302 | 302 | 298 | $19K |
| Tenofovir Disoproxil Fumarate Generic | 167 | 195 | 23 | $15K |
| Entecavir Generic | 159 | 214 | 20 | $17K |
| Ursodiol Generic | 46 | 60 | Under 11 | $4,099 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 38 | 38 | 38 | $543 |
| Azathioprine Generic | 24 | 24 | Under 11 | $278 |
| Esomeprazole Magnesium Generic | 21 | 21 | Under 11 | $258 |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 19 | 19 | Under 11 | $4,386 |
| Pantoprazole Sodium Generic | 17 | 17 | Under 11 | $62.72 |
| Amoxicillin Generic | 15 | 15 | 14 | $75.88 |
| Mesalamine Er Mesalamine | 15 | 15 | Under 11 | $847 |
| Clarithromycin Generic | 15 | 15 | 15 | $439 |
| Famotidine Generic | 13 | 14 | Under 11 | $160 |
Brand drugs: 493 claims; generic drugs: 1,444 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Danny Chu $78K ($78K in general payments such as food, travel and fees) from 9 companies. The largest payer was Madrigal Pharmaceuticals with $63K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 44 | $63K |
| Gilead Sciences, Inc. GILD | 31 | $14K |
| Abbvie Inc. ABBV | 1 | $153 |
| Medtronic, Inc. MDT | 1 | $111 |
| Janssen Biotech, Inc. JNJ | 2 | $51.78 |
| Abbott Laboratories ABT | 1 | $48.76 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $39.44 |
| Ardelyx, Inc. ARDX | 1 | $29.07 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $18.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.